Royal Bank of Canada’s Repare Therapeutics RPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $0 | Sell |
280
-2,115
| -88% | – | ﹤0.01% | 6840 |
|
|
2025
Q1 | $2K | Buy |
2,395
+2,120
| +771% | +$1.77K | ﹤0.01% | 6199 |
|
|
2024
Q4 | $0 | Hold |
275
| – | – | ﹤0.01% | 6606 |
|
|
2024
Q3 | $1K | Sell |
275
-2,156
| -89% | -$7.84K | ﹤0.01% | 6268 |
|
|
2024
Q2 | $8K | Buy |
2,431
+2,146
| +753% | +$7.06K | ﹤0.01% | 6031 |
|
|
2024
Q1 | $1K | Sell |
285
-744
| -72% | -$2.61K | ﹤0.01% | 6397 |
|
|
2023
Q4 | $8K | Sell |
1,029
-371
| -27% | -$2.88K | ﹤0.01% | 6024 |
|
|
2023
Q3 | $17K | Sell |
1,400
-693
| -33% | -$8.42K | ﹤0.01% | 5743 |
|
|
2023
Q2 | $22K | Buy |
2,093
+1,460
| +231% | +$15.3K | ﹤0.01% | 5714 |
|
|
2023
Q1 | $6K | Sell |
633
-49
| -7% | -$464 | ﹤0.01% | 6128 |
|
|
2022
Q4 | $10K | Buy |
682
+57
| +9% | +$836 | ﹤0.01% | 6079 |
|
|
2022
Q3 | $8K | Hold |
625
| – | – | ﹤0.01% | 6056 |
|
|
2022
Q2 | $9K | Hold |
625
| – | – | ﹤0.01% | 5965 |
|
|
2022
Q1 | $9K | Sell |
625
-278
| -31% | -$4K | ﹤0.01% | 6520 |
|
|
2021
Q4 | $20K | Sell |
903
-425
| -32% | -$9.41K | ﹤0.01% | 6278 |
|
|
2021
Q3 | $35K | Buy |
1,328
+60
| +5% | +$1.58K | ﹤0.01% | 5847 |
|
|
2021
Q2 | $40K | Sell |
1,268
-88
| -6% | -$2.78K | ﹤0.01% | 5689 |
|
|
2021
Q1 | $41K | Buy |
1,356
+627
| +86% | +$19K | ﹤0.01% | 5517 |
|
|
2020
Q4 | $25K | Buy |
729
+529
| +265% | +$18.1K | ﹤0.01% | 5412 |
|
|
2020
Q3 | $6K | Buy |
200
+100
| +100% | +$3K | ﹤0.01% | 5602 |
|
|
2020
Q2 | $3K | Buy |
+100
| New | +$3K | ﹤0.01% | 5728 |
|